Research Grid Raised $6.48M to Drive Automation in Clinical Trials

Research Grid has secured $6.48 million in seed funding, led by Fuel Ventures, with additional support from Arve Capital, Ada Ventures, and Morgan Stanley Inclusive Ventures Lab, among others. The funding will advance Research Grid’s mission to automate the back-office administration of clinical trials, aiming to streamline processes across patient recruitment, data management, and reporting. Clinical trial delays, largely due to legacy software and manual tasks, currently cost up to $400 million annually per Phase 3 trial.

Research Grid's platform consists of two key products: Inclusive, which optimizes patient recruitment by offering access to 91,000 vetted global communities across 2,050 medical conditions, and TrialEngine, which automates administrative workflows during trials, from protocol setup to data extraction. Powered by proprietary AI algorithms, these products enable customers to see 98% efficiency improvements, 45% cost savings, and a 145% boost in patient engagement.

TrialEngine sysetem, from product's webpage.

Founded by Dr. Amber Hill, a neuroscientist with a background in AI, Research Grid leverages Hill's firsthand experience with the bottlenecks in clinical trials. With additional investment, the company plans to expand its R&D and engineering teams, focusing on U.S. and Asian market growth. This comes at a pivotal time, as the clinical trial market is projected to surpass $95 billion by 2029, with automation seen as a vital driver of efficiency and success.